Charles River Laboratories International Inc

Charles River Laboratories states that it has a "vested interests in influencing public policies that align with its climate change/GHG reduction strategy," and affirms a public commitment "to conduct your engagement activities in line with the goals of the Paris Agreement." The company highlights its Sustainable Design program, supported by a "$5 million Annual Sustainability Capital Fund," and notes that it "is a member of the Biopharma EHS&S Forum" and "recently joined the Pharmaceutical Supply Chain Initiative (PSCI)." However, the company does not disclose any formal policy or review process to ensure the alignment of its direct lobbying efforts, nor does it describe how it assesses or manages the positions of its trade associations against its climate objectives. We found no evidence of a named individual or formal body overseeing or reviewing its lobbying activities, and no indication of any monitoring, sign-off, or audit mechanism for climate lobbying alignment, indicating limited governance of its policy engagement.